Real-life experiences on the clinical management of
Drug-Drug Interactions (DDIs) in the provision of HIV healthcare

Have you managed a patient on an unboosted INSTI with an enzyme inducer? We’re gathering real-world clinical cases to deepen our understanding of drug interactions between unboosted integrase inhibitors (like dolutegravir or bictegravir) and enzyme inducers (such as rifampicin or carbamazepine).
Your experience could help improve prescribing safety and guide clinical practice.
Share your case at clinicalcasesddis.com

Report a case and increase your chances of winning a grant to attend the congress of your choice in 2026. Remember, the more cases you report, the higher your chances of winning the prize! 

Check the legal terms and conditions here.